Recommendations for the use of cardiac troponin measurement in acute cardiac care

European Heart Journal

Volumn 31, Issue 18, 2010, Pages 2197-2204

  Thygesen, Kristian ^a   Mair, Johannes ^a   Katus, Hugo ^a   Plebani, Mario ^a   Venge, Per ^a   Collinson, Paul ^a   Lindahl, Bertil ^a   Giannitsis, Evangelos ^a   Hasin, Yonathan ^a   Galvani, Marcello ^a   Tubaro, Marco ^a   Alpert, Joseph S ^a   Biasucci, Luigi M ^a   Koenig, Wolfgang ^a   Mueller, Christian ^a   Huber, Kurt ^a   Hamm, Christian ^a   Jaffe, Allan S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

99th percentile decision level; Cardiac biomarkers; Cardiac troponin I; Cardiac troponin T; Cardiac troponins; Myocardial infarction; Myocardial injury; Myocardial necrosis; Troponin assay impression; Troponin assays

Indexed keywords

TN ANTIGEN; TROPONIN C; TROPONIN I; TROPONIN T;

CARDITIS; CORONARY ARTERY DISEASE; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEMODYNAMIC STRESS; KIDNEY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 77956943712     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq251     Document Type: Review

References (78)

1. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-2538.
2. Apple FS, Jesse RL, Newby LK, Wu AHB, Christenson RH, the NACB committee members, Apple FS, Christenson RH, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Panteghini M, Tate J, Wu AHB, the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD). National Academy of Clinical Biochemistry and IFCC Committee on Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-551.
3. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, Wu AH, Christenson RH, Apple FS, Francis G, Tang W. National Academy of Clinical Biochemistry practice guidelines: clinical characteristics and utilization of biomarkers in acute coronary syndromes. Clin Chem 2007;53:552-574. (Pubitemid 46580223)
4. Panteghini M, GerhardtW, Apple FS, Dati F, Ravkilde J, Wu AH. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001;39:174-178.
5. Parmacek MS, Solaro RJ. Biology of troponin complex in cardiac myocytes. Prog Cardiovasc Dis 2004;47:159-176.
6. Remppis A, Scheffold T, Greten J, Haass M, Greten T, Kübler W, Katus HA. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995; 27:793-803.
7. Adams JE III, Schechtman K, Landt V, Landenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994;40:1291-1295.
8. Peronnet E, Becquart L, Poirier F, Cubizolles M, Choquet-Kastylevsky G, Jolivet-Reynaud C. SELDI-TOF MS analysis of the cardiac troponin I forms present in plasma from patients with myocardial infarction. Proteomics 2006;6: 6288-6299.
9. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modifications detected in serum from patients with acute myocardial infarction. Circulation 2000;102:1221-1226.
10. Michielsen ECHJ, Diris JHC, Kleijnen VWVC, Wodzig WKWH, Van Dieijen-Visser MP. Interpretation of cardiac troponin T behaviour in size-exclusion chromatography. Clin Chem Lab Med 2006;44:1422-1427.
11. Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lövgren T, Severina ME, Pulkki K, Vuopio-Pulkki LM, Gusev NB. Troponin I is released in blood stream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997;43:1379-1385.
12. Wu AHB, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor G. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998; 44:1198-1208.
13. Hessel MHM, Michielsen ECHJ, Atsma DE, Schalij MJ, van der Valk EJM, Bax WH, Hermens WT, van Dieijen-Visser MP, van der Laarse A. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp Mol Pathol 2008; 85:90-95.
14. Eriksson S, Ilva T, Becker C, Lund J, Porela P, Pulkki K. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. Clin Chem 2005;51:848-855. (Pubitemid 40577921)
15. Adamczyk M, Brashear RJ, Mattingly PG. Prevalence of autoantibodies to cardiac Troponin T in healthy blood donors. Clin Chem 2009;55:1592-1593.
16. Katus HA, Looser S, Hallermayer K, Remppis A, Scheffold T, Borgya A, Essig U, Geuss U. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992;38:386-393.
17. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PA, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause falsepositive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998;44:1919-1924. (Pubitemid 28405756)
18. Ricchiuti V, Apple FS. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem 1999;45:2129-2135.
19. Kurz K, Giannitsis E, Zehelein J, Katus HA. Highly sensitive troponin T values remain constant after brief exercise- or pharmacological-induced reversible myocardial ischemia. Clin Chem 2008;54:1234-1238.
20. Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009;30:162-169.
21. Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 2008;51:307-314.
22. Vasile VC, Babuin L, Giannitsis E, Katus HA, Jaffe AS. Relationship of MRIdetermined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction. Clin Chem 2008;54:617-619.
23. Uettwiller-Geiger D, Wu AH, Apple FS, Jevans AW, Venge P, Olson MD, Darte C, Woodrum DL, Roberts S, Chan S. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002;48:869-876.
24. Gerhardt W, Nordin G, Herbert AK, Burzell BL, Isaksson A, Gustavsson E, Haglund S, Müller-Bardorff M, Katus HA. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000;46:817-821.
25. Snyder JA, Rogers MW, King MS, Phillips JC, Chapman JF, Hammett-Stabler CA. The impact of hemolysis on Ortho-Clinical Diagnostics ECi and Roches elecsys immunoassay systems. Clin Chim Acta 2004;348:181-187.
26. Christenson RH, Duh SH, Apple FS, Bodor GS, Bunk DM, Panteghini M, Welch MJ, Wu AH, Kahn SE. Towards standardization of cardiac troponin I measurements Part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. Clin Chem 2006;52:1685-1692.
27. Bunk DM, Welch MJ. Characterization of a new certified reference material for human cardiac troponin I. Clin Chem 2006;52:212-219.
28. Panteghini M, Bunk DM, Christenson RH, Katrukha A, Porter RA, Schimmel H, Wang L, Tate JR, IFCC Working Group on Standardization of Troponin I. Standardization of troponin I measurement: an update. Clin Chem Lab Med 2008;46: 1501-1506.
29. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-261.
30. Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008;46: 1489-1500.
31. Tate JR, Ferguson W, Bais R, Kostner K, Marwick T, Carter A. The determination of the 99th centile level for cardiac troponin assays in an Australian reference population. Ann Clin Biochem 2008;45:275-288.
32. Panteghini M. A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins. Clin Chem Lab Med 2009;47: 1179-1182.
33. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the biochemistry subcommittee of the joint European Socienty of Cardiology/American College of Cardiology/American Heart Association/World Heart Federation task force for the definition of myocardial infarction. Clin Chem 2010;56:941-943.
34. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AH, Jaffe AS. Validation of the 99th percentile cut-off independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005;51: 2198-2200.
35. Parvin CA, Apple FS. Mathematical modeling: assumptions affect results (letter, author reply). Clin Chem 2006;52:1609.
36. Kupchak P, Wu AHB, Ghani F, Newby LK, Oman ME, Christenson RH. Influence of imprecision on ROC curve analysis for cardiac markers. Clin Chem 2006;52: 752-753.
37. Kim WJ, Laterza OF, Hock KG, Pierson-Perry JF, Kaminski DM, Mesguich M, Braconnier F, Zimmermann R, Zaninotto M, Plebani M, Hanna A, Cembrowski GS, Scott MG. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. Clin Chem 2002;48: 1028-1034.
38. Eriksson S, Halenius H, Pukki K, Hellman J, Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin I autoantibodies. Clin Chem 2005;51:839-847. (Pubitemid 40577920)
39. Hickman PE, Badrick T, Wilson SR, McGill D. Reporting of cardiac troponin- problems with the 99th population percentile. Clin Chim Acta 2007;381:182-183.
40. Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Long-term health outcomes associated with detectable troponin I concentrations. Clin Chem 2007;53:220-227.
41. Schulz O, Kirpal K, Stein J, Bensch R, Berghöfer G, Schimke I, Jaffe AS. Importance of low concentrations of cardiac troponins. Clin Chem 2006;52:1614-1615.
42. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009;55:85-92.
43. Schulz O, Paul-Walter C, Lehmann M, Abraham K, Berghöfer G, Schimke I, Jaffe AS. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying CAD. Am J Cardiol 2007;100:764-769.
44. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008;155: 208-214.
45. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-58.
46. Fraser CG. Reference change values: the way forward in monitoring. Ann Clin Biochem 2009;46:264-265.
47. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:1086-1090.
48. MacRae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem 2006;52: 812-818.
49. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-867.
50. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, Sinning CR, Eleftheriadis MS, Wild PS, Schnabel RB, Lubos E, Jachmann N, Genth-Zotz S, Post F, Nicaud V, Tiret L, Lackner KJ, Münzel TF, Blankenberg S. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-877.
51. Eggers KM, Oldgren J, Nordenskjold A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574-581.
52. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, Jaffe AS. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000;140:917-927.
53. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001;38:478-485.
54. Wong GC, Morrow DA, Murphy S, Kraimer N, Pai R, James D, Robertson DH, Demopoulos LA, DiBattiste P, Cannon CP, Gibson CM. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat angina with aggrastat and determine cost of therapy with an invasive or conservative strategy-thrombolysis in myocardial infarction. Circulation 2002;106:202-207.
55. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism a meta-analysis. Circulation 2007;116:427-433.
56. Khan NA, Hemmelgam BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease a meta-analysis. Circulation 2005;112:3088-3096.
57. Nienhuis MB, Ottervanger JP, Bilo HJG, Dikkeschei BD, Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Cath Cardiovasc Interven 2008;71:318-324.
58. Christiansen JP, Edwards C, Sinclair T, Armstrong G, Scott A, Patel H, Hart H. Detection of myocardial scar by contrast-enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic CAD. Am J Cardiol 2006;97:768-771.
59. Bellenger NG, Peebles C, Harden S, Dawkins K, Curzen N. Troponin-positive chest pain with unobstructed coronary arteries: a role for delayed enhanced cardiovascular magnetic resonance in the diagnosis of non-ST elevation myocardial infarction. J Invasive Cardiol 2006;8:594-598.
60. Martinez MW, Babuin L, Syed IS, Feng DL, Miller WL, Mathew V, Breen JF, Jaffe AS. Myocardial infarction with normal coronary arteries: a role for MRI? Clin Chem 2007;53:995-996.
61. Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW, Pennell DJ, Prasad SK. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007;28:1242-1249.
62. Blich M, Sebbag A, Attias J, Aronson D, MarkiewiczW. Cardiac troponin elevation in hospitalized patients without acute coronary syndromes. Am J Cardiol 2008;101: 1384-1388.
63. Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, Jaffe AS. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med 2008;36:759-765.
64. Landesberg G, Shatz V, Akopnik I, Wolf YG, Mayer M, Berlatzky Y, Weissman C, Mosseri M. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 2003;42:1547-1554.
65. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men. Circulation 2006;113:1071-1078.
66. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, Wians F, Sabatine MS, Morrow DA, de Lemos JA. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-1965.
67. Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol 2008;52:450-459.
68. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, Yasskiy A. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005;111:310-314.
69. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2007;103: 2035-2037.
70. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106:2941-2945.
71. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006;92:804-809.
72. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54: 1165-1172.
73. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a nextgeneration, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009;55:573-577.
74. Wu AH, Fukushima N, Puskas R, Todd J, Goix P. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem 2006;52:2157-2159.
75. Apple FS. A new season for cardiac troponin assays: its time to keep a scorecard. Clin Chem 2009;55:1303-1306.
76. Melanson SEF, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007;128:282-286.
77. WuAHB, Agee SJ, Lu QA, Todd J, Jaffe AS. Specificity of a high-sensitivity cardiac troponin I assay using single-molecule-counting technology. Clin Chem2009;55:196-198.
78. Morrow DA, Antman EM. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem 2009;55:5-8